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Abstract: The present discourse links the electrical and chemical properties of the brain 
with neurotransmitters and movement behaviors to further elucidate strategies to diagnose 
and treat brain disease. Neuromolecular imaging (NMI), based on electrochemical 
principles, is used to detect serotonin in nerve terminals (dorsal and ventral striata) and 
somatodendrites (ventral tegmentum) of reward/motor mesocorticolimbic and nigrostriatal 
brain circuits. Neuronal release of serotonin is detected at the same time and in the same 
animal, freely moving and unrestrained, while open-field behaviors are monitored via 
infrared photobeams. The purpose is to emphasize the unique ability of NMI and the 
BRODERICK PROBE® biosensors to empirically image a pattern of temporal synchrony, 
previously reported, for example, in Aplysia using central pattern generators (CPGs), 
serotonin and cerebral peptide-2. Temporal synchrony is reviewed within the context of the 
literature on central pattern generators, neurotransmitters and movement disorders. 
Specifically, temporal synchrony data are derived from studies on psychostimulant 
behavior with and without cocaine while at the same time and continuously, serotonin 
release in motor neurons within basal ganglia, is detected. The results show that temporal 
synchrony between the neurotransmitter, serotonin and natural movement occurs when the 
brain is NOT injured via, e.g., trauma, addictive drugs or psychiatric illness. In striking 
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contrast, in the case of serotonin and cocaine-induced psychostimulant behavior,  
a different form of synchrony and also asynchrony can occur. Thus, the known 
dysfunctional movement behavior produced by cocaine may well be related to the loss of 
temporal synchrony, the loss of the ability to match serotonin in brain with motor activity. 
The empirical study of temporal synchrony patterns in humans and animals may be more 
relevant to the dynamics of motor circuits and movement behaviors than are studies of 
static parameters currently relied upon within the realms of science and medicine. There 
are myriad applications for the use of NMI to discover clinically relevant diagnoses and 
treatments for brain disease involving the motor system. 
Keywords: neurotransmitters; behavior; brain; dopamine; serotonin; nigrostriatal pathway; 
mesocorticolimbic pathway; cocaine; dystonia; spinal cord injuries; central pattern 
generators; movement disorders; temporal synchrony; atemporal synchrony; drug addiction; 
psychiatric disorders; neurodegenerative diseases 
 
1. Temporal Synchrony between Neurotransmitters and Movement within Motor Circuits 
NMI and the BRODERICK PROBE® can be utilized to study movement disorders whether these 
movement disorders originate in the brain or the spinal cord. This NMI biotechnology actually images 
neurotransmitters at the same time that movement occurs. Moreover, in dystonic movement injury, e.g., 
a BRODERICK PROBE® biosensor can be inserted into neurons of muscle and ganglia in situ or  
in vivo, enabling real time studies of neurotransmitters within these motor neurons on line while 
monitoring movement behavior at the same time. Indeed, the brain’s motor neurons, the basal ganglia 
are the neuroanatomic substrates known to produce sequential movement, adapt reward movement and 
perform such functions as promoting motor learning and planning. Therefore, such a technological 
advance as NMI which allows BRODERICK PROBE® biosensors to sense neurochemistry on line 
with behavior provides potential diagnostic and therapeutic interventions for brain and spinal cord 
injuries previously unavailable. Presented, are empirical data, performed by NMI, demonstrating a 
unique temporal synchrony between neurotransmitters and behavior as neurotransmitters are imaged 
within the basal ganglia nuclei. The most important findings are that (a) temporal synchrony between 
brain neurotransmitter and behavior occurs when endogenous serotonin release in basal ganglia is 
imaged on line with natural behaviors and (b) psychostimulant-induced behavior, monitored on line 
while serotonin release is imaged in basal ganglia, produces a different form of synchrony and/or 
temporal asynchrony. Temporal patterns enable a new and dynamic data profile useful clinically and 
pre-clinically. Although static neurotransmitter levels, currently the standard, are valuable, static 
parameters become more valuable when empirically studied within the context of movement. Other 
disorders of basal ganglia, such as athetoid and dystonic disease can be studied with the BRODERICK 
PROBE®. An example of an athetoid, dystonic disease, is Lesch-Nyhan syndrome (LNS).  
LNS is characterized by severe athetoid and dystonic movements, self-mutilation, and repetitive 
oral stereotypies, similar to fine movement behaviors of licking and grooming observed in rodents 
which is produced by rewarding drugs, such as psychostimulants. Patients suffering from LNS may be 
Brain Sci. 2013, 3 994 
 
 
required to have teeth removed to avoid oral stereotypies that cause the patient to devour lips, tongues 
or fingers. The stereotypies involve dopamine and serotonin [1] and high levels of uric acid [2]. Other 
athetoid, dystonic diseases and spinal cord injury, drug addiction and psychiatric disorders are 
discussed within the context of these miniature nano-biosensors that comprise the BRODERICK 
PROBE® [3–7]; this biosensor is approved by the Institutional Review Board, NYU Tisch Hospital for 
intraoperative studies in epilepsy patients; studies are published [8]. 
2. The Basal Ganglia 
In order to examine NMI as this biotechnology relates to the experience of temporal synchrony, let 
us first look at the basal ganglia. The basal ganglia is a complex neuroanatomic substrate targeted by 
injuries involving movement, cognition and reward, each connected through separate motor and limbic 
loops within the neuronal ganglia per se. The basal ganglia, comprised of basal nuclei are paired 
subcortical masses or nuclei of gray matter that include the dorsal striatum, (caudate putamen and the 
globus pallidum) and the ventral striatum. The caudate and putamen are structurally distinct in the 
human and these structures are joined in lower mammals and are generally considered to function as a 
unit, called striatum. The terminology, striatum, is derived from the striped nature of this 
neuroanatomic substrate. Coursing through the striatum and closely related, is the internal capsule 
which separates striatum from the lenticular nucleus. Also closely associated with the basal ganglia 
nuclei are small brain-stem nuclei, the substantia nigra, the ventral tegmentum and the subthalamus. 
The control of voluntary movement is executed by the interaction of the pyramidal, cerebellar, and 
extrapyramidal systems, which interconnect with each other as well as projecting to the cranial  
nerve nuclei. The nigrostriatal and mesocorticolimbic pathways are depicted in Figure 1. 
Figure 1. A schematic diagram showing dopamine in nigrostriatal and mesocorticolimbic 
pathways in basal ganglia. Note: this figure is adapted with permissions from [9,10]. 
Copyright Humana Press, 2002 and Upjohn Company, 1980. 
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Dopamine is a critical neurotransmitter that projects from the substantia nigra to the dorsal striatum 
(A9) with parallel circuitry, the mescorticolimbic (A10) neurons emanating from the ventral tegmental 
area to what is commonly called, “the reward center”, (nucleus accumbens), which is part of the 
ventral striatum. When we think about the ventral striatum as actually being the “limbic loop” of the 
motor ganglia which encompasses reward mechanisms, this could possibly mean that stroke victims 
cannot feel reward in addition to being motor impaired. Therefore, it is important to find medications 
that treat both the movement and the brain reward disorders. NMI contributed to such a medication for 
stroke. It was found that Lovenox® a medication for stroke, increased serotonin release in basal ganglia 
of stroked animals on line, in vivo, with increased blood flow. In these studies, NMI simultaneously 
and selectively imaged neuronal serotonin release in the motor circuit of the murine brain, the dorsal 
striatum while at the same time, Dual Laser Doppler sensors monitored blood flow [11]. 
These small gray-matter nuclei, basal nuclei, comprise the basal ganglia. Although these structures 
lie deep within the forebrain and hindbrain, they are anatomically away from parts of the cortical area 
and yet, they still have multi-faceted neuronal connections with the cortex. Electrophysiological 
studies in primates, in addition to movement and cognitive studies in patients with dysfunctional 
movement, have shown that the basal nuclei operate to assist in movement to (1) determine force and 
velocity, (2) prepare for movement, (3) develop automaticity, (4) promote sequential movement,  
(5) inhibit unwanted movement, (6) adapt to novel or reward movement and (7) motor learning and 
planning [10]. 
3. The Cortico-Basal Ganglia Network 
The A10 terminal neurons of the mesocorticolimbic circuit is now considered to be the ventral part 
of the dorsal striatum and this is, as mentioned, the reward circuit, the limbic loop in the basal ganglia. 
In fact, the reward circuit, is now considered to be embedded within the cortico-basal ganglia network, 
and is a central component for developing and monitoring motivated behaviors. In the past, the basal 
ganglia were best known for their relevance to motor functions, based on the neuropathology of 
movement disorders and the idea that basal ganglia pathways return primarily to motor cortex [12]. 
Therefore, there has been quite a conceptual leap during the last three decades, with reports showing 
that the function of the basal ganglia is not a purely motor or sensory-motor worker but the ganglia 
perform a more complex set of functions that mediate the full range of goal-directed behaviors, 
including emotions, motivations, and cognitions. The conceptual leap came about from several lines of 
inquiry and one of these reports, was the demonstration that frontal cortical information passing 
through the basal ganglia returns to the whole entity of the frontal cortex [13,14]. 
4. NMI in the Dorsal and Ventral Striatum: The Monoamines 
To look further into NMI, neurotransmitters and brain anatomy, let us look into how the dorsal and 
ventral striata were distinguished early on by using pharmacology. In pioneering studies by the 
NOBEL laureate, Dr. Arvid Carlsson, significant amounts of dopamine were found in the basal 
nucleus, the dorsal striatum, the A9 nerve terminal [15]. The somatodendrites for the A9 region are 
called substantia nigra (black body) which Bertler found to contain dopamine as well; the data were 
reported approximately two years after Carlsson’s finding of dopamine in the dorsal striatum [16]. 
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Monoamine histochemistry soon followed and dopamine was visualized in cell bodies and nerve 
terminals of the A9 region by the Falck et al. technology [17]. Indeed, the A9 region was found to be 
the largest dopamine containing pathway originating in the subanatomy of substantia nigra, the pars 
compacta [17–20]. Figure 2 depicts immunocytographs of dopamine (DA) and serotonin (5-HT) in 
nucleus accumbens (NAc) of Sprague Dawley laboratory animals at the site of the BRODERICK 
PROBE® biosensor. 
Figure 2. Immunocytographs of dopamine (DA) and serotonin (5-HT) in nucleus 
accumbens (NAc) (ventrolateral (vl)) of Sprague Dawley laboratory rats. Dark field 
photomicrographs show the distribution of (A) DA neurons, stained with tyrosine 
hydroxylase; two high density patterns of DA are apparent in the medial and lateral core, 
(B) 5-HT axons in the caudal one-third of NAcc; 5-HT was stained with a sensitive silver 
intensification procedure, thus axons and terminals are black, (C) 5-HT axons in DA 
neurons in NAcc at the site of the BRODERICK PROBE® laurate biosensor. In (B), two 
low density patterns of 5-HT are apparent in the ventral and ventrolateral NAcc. High 
density 5-HT is seen in the perimeter around the core. A scale = 500 μm as shown by the 
horizontal line in the bottom left part of Figure 2A, Direct efferent neurons derive from 
VTA to vlNAcc. (D) Coronal section of NAcc depicting vlNAcc is adapted with 
permissions from [21]. Copyright Elsevier Limited, 1997. 
 
Dopamine in the ventral tegmental pathway, cell bodies for A10 circuit, adjacent to the nigrostriatal 
pathway, was reported by Anden et al. 1966 [22]. The A9 and A10 dopamine circuits were further 
distinguished from each other in terms of psychomotor stimulant behavior. In further studies, the 
neurotoxin, 6 hydroxydopamine (6-OHDA) was used to lesion the basal nucleus, A9 striatum and the 
result was to eliminate the classical stereotyped repetitive responses of fine movements such as 
grooming [23]. Then, a psychomotor stimulant was injected into basal nuclei, A10, nucleus accumbens 
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and olfactory tubercle and the result was the production of locomotor hyperactivity [24]. There is now 
an extensive empirical body of evidence pointing to psychostimulant directed dysfunctional movement 
behaviors due to affected dopamine in basal ganglia. Cocaine was found to increase serotonin as well 
as dopamine release in nigrostriatal and mesocorticolimbic nerve terminals and somatodendrites in 
1992 and 1993 [25–27]. In the late nineties, the indoleamine, serotonin was found to be present within 
the dopamine reward pathway, A10, at the site of the BRODERICK PROBE® [9–21].  
Dorsal (A9) and ventral (A10) dopamine pathways have been a major focus of study in this 
laboratory [25–28]. Precise distinctions between and within the dorsal and ventral striatal substrates, as 
delineated by a number of different formulations of the BRODERICK PROBE® are published [3–7]. 
This is the first laboratory to separately image endogenous monoamines, indoleamines and peptide 
neurotransmitters on line with natural movement in the animal subject [9,21]. The focus of the present 
paper is the indoleamine, serotonin. 
5. Temporal Synchrony, Central Pattern Generators 
Now, let us look into the concept of temporal synchrony, into the phenomenon of rhythmic 
movement itself, which is often produced by a neuronal network capable of generating a rhythmic 
pattern of motor activity either in the presence or absence of phasic sensory input from peripheral 
receptors; this is called a Central Pattern Generator (CPG). Indeed, CPGs have been identified and 
analyzed in more than 50 rhythmic motor systems and CPGs can generate a variety of motor patterns. 
A universal characteristic of this wide variety of motor patterns is that they consist of rhythmic and 
alternating motions of the body or appendages. It is the rhythmicity of these behaviors that make these 
behaviors appear stereotypic or repetitive. It is the repetitive quality of these behaviors that enables 
stereotypic behaviors to be controlled automatically. This automaticity or autoactivity means that  
there may be little or no need for intervention from higher brain centers when the environment  
remains stable. 
The simplest CPGs contain neurons that are able to burst spontaneously. Such endogenous bursters 
can drive other motor neurons and some motor neurons are themselves, endogenous bursters. 
Importantly, bursters are common in CPGs that produce continuous rhythmic movement, such as 
locomotion. But, locomotion is an episodic, rhythmic behavior and thus, further regulation by 
neurotransmitters, such as dopamine and/or serotonin in motor circuits becomes necessary. 
Endogenous bursts (cell firing) of neurons involved in locomotion must be regulated by 
neurotransmitters and neuromodulators, i.e., substances that can alter the cellular properties of neurons 
involved in CPGs.  
Brief depolarizations occur and lead to maintained depolarizations (plateau potentials) that can last 
for long periods of time. These maintained depolarizations far outlast the initial depolarization and it is 
these maintained depolarizations that are necessary for rhythmic movements. The generation of 
rhythmic motor activity by CPGs can be altered by amines and peptides [29,30], thereby enabling a 
CPG to generate an even greater variety of repetitive motor patterns. Motor CPGs produce a complex 
temporal pattern of activation of different groups of motor functions and each pattern can be divided 
into a number of distinct phases even within a phase. CPGs are also time-dependent [31]. 
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6. Serotonin Is a Neuromodulator for CPGs 
In fact, serotonin (5-HT) can control the CPG underlying the escape swim response in the mollusc, 
Tritonia diomedea. Interestingly, the dorsal swim interneurons (DSI’S) are a bilaterally represented set 
of three 5-HTergic neurons that participate in the generation of the rhythmic swim motor program. 
Serotonin from these CPG neurons is said to function as both a fast neurotransmitter and as a slower 
neuromodulator. In its modulatory role, 5-HT enhances the release of neurotransmitter from another 
CPG neuron, C2 and also increases C2 excitability by decreasing spike frequency adaptation. Serotonin, 
intrinsic to the CPG, may neuromodulate behavioral sensitization and habituation. Serotonin intrinsic 
to the DSI enhances synaptic potentials evoked by another neuron in the same circuit [32,33]. 
In another mollusc, the pteropod Clione limacina, the CPG for swimming is located in the pedal 
ganglia and formed by three groups of interneurons which are critical for rhythmic activity. The 
endogenous rhythmic activity of this CPG was enhanced by 5-HT [34]. In the pond snail, Lymnaea 
stagnalis, 5-HT is the main neurotransmitter in its stereotypic feeding circuit [35]. In the sea slug, 
Aplysia, the CPG for biting is modulated both intrinsically and extrinsically. Intrinsic modulation has 
been reported to be mediated by cerebral peptide-2 (CP-2) containing CB1 2 interneurons and is 
mimicked by application of CP-2. On the other hand, extrinsic modulation of the CPG for stereotypic 
biting in the sea slug, is mediated by the 5-HT-ergic metacerebral cell (MCC) neurons and this 
behavior is mimicked by application of 5-HT [36]. 
In vertebrates, the 5-HT somatodendritic nuclei, the raphe nuclei, comprise the most expansive and 
complex anatomic and neurochemical system in the Central Nervous System (CNS). Raphe nuclei 
almost exclusively reside along the midline in the rodent and in the primate. Fewer raphe nuclei reside 
along the midline [37]. The rostral 5-HT raphe group and caudal linear nucleus sends 5-HT efferents to 
A9 dopaminergic (DA-ergic) basal ganglia motor nuclei and the caudal 5-HT group as well, whereas 
the interfascicular aspect of the 5-HTergic dorsal raphe projects efferents to A10 dopaminergc  
(DA-ergic) basal ganglia motor nuclei [38]. 
Electrophysiological studies have shown that the most prominent action of increased 5-HT cell 
firing in 5-HT somatodendrites, dorsal raphe (DR), is to increase the flexor and extensor burst 
amplitude of 5-HT cell firing in DR during the act of treadmill locomotion [39]. Further evidence for 
5-HT controlling motor output is seen from studies in which 5-HT, directly injected into the motor 
nucleus of the trigeminal nerve, increased the amplitude of both the tonic electromyogram of the 
masseter muscle and the externally elicited jaw-closure (masseteric) reflex [40–42]. Indeed, Jacobs and 
Azmitia have proposed that 5-HT’s primary function in CNS neuronal circuitry is to facilitate motor 
output [38]. 
Serotonin neurons within 5-HT somatodendrites depolarize with such extraordinary regularity that 
they exhibit automaticity, i.e., they can act by CPGs and produce plateau potentials. Thus, 5-HT 
neurons exhibit repetitive discharge characteristics. Increased 5-HT neuronal cell firing in 
somatodendritic raphe nuclei generally precedes the onset of movement or even increased muscle tone 
in arousal by several seconds and is maintained during sustained behavior [43]. Importantly, 5-HT cell 
firing in raphe nuclei is sometimes phase-locked to repetitive behavioral stereotypic responses. The 
regular firing of 5-HT somatodendrites in raphe nuclei is activated preferentially. This activation is 
associated with locomotion and chewing, stereotypic behaviors that are stimulated by CPGs [44]. 
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Serotonin intrinsic CPGs have been reported to be responsible for inducing rhythmic motor activity in 
the spinal cord of the turtle and the lamprey [45,46]. The evidence in the lamprey suggests that 5-HT 
may have a role in the generation of a family of related undulatory movements including swimming, 
crawling, and burrowing by using one single CPG. 
7. Serotonin Is a Neuromodulator for Natural Movement.  
NMI with the BRODERICK PROBE® was used to study the continuous empirical relationship 
between endogenous serotonin release in basal ganglia and natural movement behavior which is 
directed by basal ganglia per se. Specific studies imaging serotonin release in dopaminergic  
(DA-ergic) motor/reward pathways in (1) the nerve terminals, A9, dorsal striatum (DStr), (2) nerve 
terminals, A10, ventral striatum (nucleus accumbens) (NAcc) and (3) somatodendrites (cell bodies), 
Ventral Tegmental Area (VTA), were performed, in vivo. NMI enables empirical studies in  
each animal subject as its own control. Studies are described in detail in published patents from this 
laboratory [3–7]; an extensive interpretation and discussion of the neurotransmitter mechanisms 
involved in motor circuits are reported [9–21]. Movement behaviors in animals are discussed as  
open-field behavior with two components emphasized, i.e., ambulations and fine movements [47]. 
NMI and movement behaviors are synchronized in 5 min intervals. The experimental design for these 
studies was chosen according to the needs of the open-field behavioral paradigm. The BRODERICK 
PROBE® images neurotransmitters selectively within a temporal resolution as low as milliseconds. 
It is important to describe open-field behavior: 
• ambulations (locomotion, walking/running, repeatedly);  
• fine movements (stereotypy, behaviors of chewing, licking and grooming); 
• rearing (standing movement with front paws extended upward); 
• central ambulations (motor behavior taking place in the center of the chamber; central 
ambulations are believed to be a measure of anxiety, a fear of open places, called 
agoraphobia/thigmotaxis. 
Some important properties of NMI are: 
• Each neurotransmitter, imaged selectively via NMI, exhibits a distinct voltage potential at which 
oxidation or reduction occurs; this results in a recording which has a distinct peak (waveform) 
for a specific neurotransmitter; 
• The concentration of each neurotransmitter within the synaptic environment is directly related to 
the current as shown by the Cottrell Equation; 
• Each neurotransmitter is detected within seconds (semiderivative circuit). Chronoamperometric 
circuit images within milliseconds; 
• NMI is comprised of several formulations and configurations for the BRODERICK PROBE® 
series of microelectrodes and biosensors. 
The following line graphs show serotonin release plotted versus separate natural (no drug)  
open-field behaviors of Ambulations (Locomotion) and Fine Movements (Chewing, Licking, Grooming). 
The results in Figure 3A show that the natural, normal episodic, rhythmic nature of locomotor 
(ambulatory movement) is neuromodulated by 5-HT within the DA-ergic basal nucleus of the A9 
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terminals, the dorsal striatum (DStr). The data exhibit temporal synchrony between serotonin in dorsal 
striatum (DStr) and natural open-field behaviors of Ambulations. Figure 3B shows temporal synchrony 
between serotonin release in the DA-ergic basal nucleus, A9, DStr and Fine Movement behaviors. 
Figure 3. (A) Ambulations. Natural neurochemistry and behavior: line graph depicting 
endogenous 5-HT release (open circles) at A9 terminals, DStr, detected in real time, while 
the freely moving, male, Sprague-Dawley laboratory rat is actually behaving, during 
normal/natural movement (first hour) and subsequent habituation behavior (second hour). 
(B) Fine movements. Natural (no drug) neurochemistry and behavior: line graph depicting 
endogenous 5-HT release (open circles) at A9 terminals, DStr, detected in real time, while 
the freely moving, male, Sprague-Dawley laboratory rat is actually behaving, during 
normal/natural movement (first hour) and subsequent habituation behavior (second hour). 
Note: the figure is adapted with permission from [21]. Copyright Elsevier Limited, 1997. 
 
 
The terms, synchronous and simultaneous, describe the relationship between serotonin release at 
distal A9 terminal fields versus open-field behaviors of ambulations (locomotion) and stereotypic fine 
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movement behavior (chewing, licking, grooming). When serotonin function in motor circuits is 
endogenous and natural, the co-relationship between the two parameters shows rhythmic regularity. 
In Figure 4A,B, serotonin release, imaged in distal A10 mesocorticolimbic terminal fields 
(ventrolateral nucleus accumbens [ventral striatum, (vlNAcc)] with open-field behavior, is shown.  
Figure 4. (A) Ambulations. Natural neurochemistry and behavior: line graph depicting 
endogenous 5-HT release (open circles) at basal nucleus, A10 terminals, vlNAcc, in real 
time, while the freely moving, male, Sprague-Dawley laboratory rat is actually behaving, 
during normal/natural movement (first hour) and subsequent habituation behavior  
(second hour). (B) Fine Movements. Natural neurochemistry and behavior: Line graph 
depicting endogenous 5-HT release (open circles) at basal nucleus, A10 terminals, vlNAcc, 
in real time, while the freely moving, male, Sprague-Dawley laboratory rat is actually 
behaving, during normal/natural movement (first hour) and subsequent habituation 
behavior (second hour). Note: the figure is adapted with permission from [21]. Copyright 
Elsevier Limited, 1997. Immunocytographs of dopamine (DA) and serotonin (5-HT) in 
nucleus accumbens (NAc) (ventrolateral (vl)) of Sprague Dawley laboratory rats.  
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The results shown in Figure 4A,B show that the natural, normal episodic, rhythmic nature of 
locomotor (Ambulatory Movement) and Fine Movement Behaviors are neuromodulated by serotonin 
(5-HT) within the DA-ergic basal ganglia, the nucleus of the A10 terminals, the ventrolateral nucleus 
accumbens (vlNAcc). Temporal synchrony is exhibited.  
Therefore, the results shown in Figures 3 and 4 show that the BRODERICK PROBE® biosensor 
inserted within nigrostriatal and mesocorticolimbic nerve terminals, (A9 and A10, respectively) is 
sensitive to the rhythmic co-relationship between the neurotransmitter, serotonin and movement. In 
each case, the biosensor is imaging neurotransmitter in the same basal ganglia that directs motor 
behavior. There is a rhythmic co-relationship between serotonin release at distal A9 and distal A10 
terminal fields and open-field behaviors of ambulations (locomotion) and stereotypic behavior 
(chewing, licking, grooming). Temporal synchrony occurs in natural neurochemistry and behavior 
when no drug, injury or trauma is present.  
NMI in vivo empirically shows a direct relationship between increased serotonin release at distal 
presynaptic sites in dopamine motor pathways on line with open-field behaviors of ambulations and 
fine movements. This is the first data of its kind, demonstrating brain/behavior mechanisms happening 
with temporally synchronous patterns. These results extend previous voltammetric data, showing that 
5-hydroxyindoleacetic acid (5-HIAA), a metabolite for serotonin, is implicated in the awake state of 
animal subjects [48]. These data, presented herein, further extend and lend an explanatory note to 
electrophysiological data [37,38,42–44] which reports that serotonin directly mediates motor output 
and maintains steady state function during sustained behavior, for example, as in habituation behavior. 
Moreover, what may be of crucial importance, are temporal synchrony patterns in dopamine A10 
somatodendrites, Ventral Tegmental Area (VTA). What does the temporal communication between 
serotonin release in VTA and the act of ambulating and/or the fine movement act of chewing look like? 
Is the increase in serotonin in VTA somatodendrites in tandem before each movement, as 
electrophysiology studies of serotonin and movement have shown?  
Thus, BRODERICK PROBE® biosensors imaged serotonin release on line with open-field behavior 
in proximal A10 ventral tegmental somatodendrites (VTA). The results are shown in Figure 5. 
Figure 5A,B show a natural, rhythmic regularity which is episodic as expected, especially in 
ambulations (locomotor behavior). The co-relationship between serotonin release in DA-ergic A10 
somatodendrites and movement behaviors are in juxtaposed temporal synchrony. 
Synchronicity describes the co-relationship; patterns are in concert between serotonin release at 
proximal VTA and open field behaviors of ambulations and fine movements. This additional new 
finding reveals a synchrony between serotonin release in VTA and open-field behaviors that appears 
temporally juxtaposed. The comparison of the NMI temporal synchrony patterns in the proximal 
presynaptic DA somatodendrites versus NMI temporal synchrony patterns in neuronal terminal basal 
nuclei (A10) is likely related to the electrophysiology of 5-HT cell firing in somatodendritic cell bodies 
in 5-HT-ergic raphe nuclei.   
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Figure 5. (A) Ambulations. Natural neurochemistry and behavior: Line graph depicting 
endogenous serotonin (5-HT) release (open circles) at nucleus, A10, somotodendrites, cell 
bodies, Ventral Tegmentum (VTA), in real time, while the freely moving, male,  
Sprague-Dawley laboratory rat is in the act of behaving, during normal/natural movement 
(first hour) and subsequent habituation behavior (second hour). (B) Fine Movements. 
Natural neurochemistry and behavior: Line graph depicting endogenous serotonin (5-HT) 
release (open circles) at nucleus, A10, somotodendrites, cell bodies, Ventral Tegmentum 
(VTA), in real time, while the freely moving, male, Sprague-Dawley laboratory rat is 
actually behaving, during normal/natural movement (first hour) and subsequent habituation 
behavior (second hour). Note: the figure is adapted with permission from [21]. Copyright 
Elsevier Limited, 1997. 
 
 
The raphe nuclei project 5-HT efferents to DA-ergic basal ganglia nuclei and act via CPG, 
stereotypic discharges that can lead to automaticity. When serotonin increases in 5-HT-ergic raphe 
nuclei, the rise in the firing rate of serotonin neurons generally precedes the onset of movement by 
several seconds [43]. It is interesting that 5-HT temporal synchrony is juxtaposed in DA-ergic VTA 
somatodendrites, (the cell bodies) in concert with movement, whereas 5-HT temporal synchrony 
appears simultaneously with motor behavior within the neuronal terminal basal nucleus (vlNAcc) in 
the DA-ergic A10 circuit. Further work is needed to interpret these novel patterns of brain/behavior 
mechanisms relating to neurotransmitter function in motor regions of brain.  
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8. Serotonin Is a Neuromodulator for Psychostimulant-Directed Movement 
Figures 6 and 7 show the disturbing effects of the psychostimulant, cocaine, on temporal synchrony 
patterns in A10 mesocorticolimbic nerve terminals and the disruptive effects of the psychostimulant, 
cocaine, on A10 somatodendrites. These results, derived from psychostimulant-directed movement, are 
in striking contrast to the results from NMI studies of natural serotonin release and movement 
behaviors. Whereas endogenous serotonin release in DA-ergic basal ganglia during natural open-field 
behaviors exhibits temporal synchrony, psychostimulant-directed serotonin release in DA-ergic basal 
ganglia exhibits different forms of temporal asynchrony. 
Figure 6. (A) Ambulations. Cocaine neurochemistry and behavior: Line graph depicting 
endogenous 5-HT release (open circles) at basal nucleus, A10 terminals, vlNAcc, in real 
time, while the freely moving, male, Sprague-Dawley laboratory rat is actually behaving, 
during cocaine-induced behavior (cocaine, 2-h study). Baseline is not shown. (B) Fine 
movements. Cocaine neurochemistry and behavior: Line graph depicting endogenous 5-HT 
release (open circles) at basal nucleus, A10 terminals, vlNAcc, in real time, while the freely 
moving, male, Sprague-Dawley laboratory rat is actually behaving, during cocaine-induced 
behavior (2-h study). Baseline is not shown. Note: the figure is adapted with permission 
from [21]. Copyright Elsevier Limited, 1997. 
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Figure 7. (A) Ambulations. Cocaine neurochemistry and behavior: line graph depicting 
endogenous 5-HT release (open circles) at basal stem nucleus, DA A10, somotodendrites, 
VTA, in real time while the freely moving, male, Sprague-Dawley laboratory rat is actually 
behaving, during cocaine-induced behavior (cocaine: 4 h). Baseline is not shown. (B) Fine 
Movements. Cocaine neurochemistry and behavior: Line graph depicting endogenous  
5-HT release (open circles) at basal stem nucleus, DA A10, somotodendrites, VTA, in real 
time, while the freely moving, male, Sprague-Dawley laboratory rat is actually behaving, 
during cocaine-induced behavior (cocaine: 4-h). Baseline is not shown. Note: the figure is 
adapted with permission from [21]. Copyright Elsevier Limited, 1997. 
 
 
In Figure 6A and furthermore, in Figure 6B, a form of temporal asynchrony is the result of 
psychostimulant-induced brain/behavior function. It is most intriguing to observe that the 
psychostimulant effect of cocaine on temporal synchrony in nerve terminal A10 basal nucleus remains 
rhythmic and episodic but not synchronous. The BRODERICK PROBE® biosensor allows such 
neuroadaptive subtleties to be imaged after a psychostimulant is injected. Such observations as these 
are critical to future pharmacotherapies for psychostimulant abuse as well as related psychiatric, 
dystonic movement disorders. It is likely that 5-HT-ergic neurons in raphe nuclei further affect the 
synchrony of DA neurons in basal ganglia with both types of open-field behaviors studied here.  
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The data in Figure 7A,B show that cocaine disrupted the natural, episodic, rhythmic nature of 
ambulatory and fine movement behaviors, neuromodulated by serotonin (5-HT) within DA-ergic basal 
stem nucleus, A10 somatodendrites. Psychostimulant effects on temporal synchrony appear to occur to 
a greater degree in somatodendrites as compared with nerve terminal nuclei.  
In summary,  
• The general and well known upward directional values for the effect of cocaine on serotonin 
release and movement behaviors in dopamine motor/reward brain circuitry are repeated  
and confirmed. 
• Previous studies have not been able to show these subtle brain alterations during 
psychostiumulant behavior, nor have these previous studies been able to monitor natural, 
episodic rhythmic nature of exploratory and habituation behavior on line with the 
neurotransmitter associated with the specific behavior.  
• Serotonin-ergic neuromodulation in A10 basal nucleus and A10 somatodendrites during natural 
movement behaviors is disrupted by cocaine.  
• There are different forms of asynchrony dependent on whether the neuroanatomic substrate 
affected is nerve terminal or somatodendrite.  
• The studies show that neuronal damage to basal nuclei and brain stem nuclei occurred after the 
administration of the psychostimulant, cocaine. 
• Neuroadaptive responses by serotonin in motor circuits is seen after a single injection of cocaine. 
• Neuroadaptation may be a pre-disposition to cocaine neurotoxicity. 
NMI data on line with open-field behavior are complementary to the electrophysiological work of 
Jacobs and Azmitia [37,38,42–44]. In the Jacobs and the Azmitia laboratories, the raphe nuclei 
(somatodendrites for serotonin) and their efferent connections to basal ganglia were the focus; the 
findings were (1) The rostral serotonin raphe group and caudal linear nucleus sends serotonin efferents 
to A9 basal nuclei motor system and the caudal linear nucleus serotonin group and (2) the 
interfasciculus aspect of the serotonin dorsal raphe projects efferents to A10 mesocorticolimbic basal 
nuclei, basal ganglia region.  
Thus, NMI enables the imaging of serotonin release in dopaminergic motor circuits in concert with 
movement behavior. The BRODERICK PROBE® real time data shows the extraordinary regularity, 
repetitive nature and automaticity of serotonin neurons on line with natural movement behavior in A9 
and in A10 nigrostriatal and mesocorticolimbic dopamine basal ganglia in brain. The data also directly 
links serotonin with the disruption of natural temporally synchronous behavior known to be caused by 
psychostimulants and dystonic brain disorders related to psychiatric and mental illness.  
These data link for the first time, the mechanism of neuronal serotonergic central pattern generators 
(CPGs) in dopaminergic basal nuclei and somatodendrites, specifically with ambulatory and 
stereotyped movement behaviors.  
9. Serotonin Is a Neuromodulator in Spinal Cord Injury 
It is known that inflammatory cytokines as well as vasoactive substances such as serotonin are 
released at the site of spinal cord injury and it has been also shown that serotonin is released in 
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ischemic injury in basal ganglia of animals [11]. In vitro work by Saruhashi et al., in 2002 [49] shows 
that the amplitude of action potential necessary for movement in the dorsal column axon of the spinal 
cord works through different mechanisms, i.e., the serotonin 1A versus the 2A receptor. These important 
studies provide strategies for pharmaceutical therapies in terms of using the serotonin 1A agonist to 
depress action potentials and assist in acute spinal cord injury. However, in an intact spinal cord injury, 
signals from the brain are telling the motor neurons to excite or depress causing muscles to contract or 
expand and since these systems are acting in concert, an in vivo model, NMI, becomes more appealing 
for study. 
A recent paper from the Bennett group (2010) [50] studied a virtual “stepping response” to show 
serotonergic temporal synchrony in a hemisected rodent model of spinal cord injury, in situ. This 
model is valuable especially since many of the neurons that normally coordinate rhythmic movements 
in mammals are located in the spinal cord [51,52] and spinal neurons require serotonin to get neurons 
ready to generate movement [53,54]. When the spinal cord is injured, spinal neurons caudal to the 
injury are serotonin deficient, leaving them “high and dry” in an unexcitable state even though injury 
did not occur at this caudal site. It is an intriguing finding by the Bennett group that locomotion after 
spinal cord injury depends on constitutive activity in serotonin receptors [50]. The data, although not  
in vivo, supports our NMI data that ambulations/locomotion are neuromodulated by serotonin. Further 
evidence for serotoninergic neuromodulation of movement is derived from data showing that 
locomotion can be regained soon after spinal transection with the exogenous application of drugs that 
activate the neuromodulatory serotonin, noradrenaline and dopamine receptors in vivo and in vitro [55–58], 
including serotonin 2 and serotonin 7 receptor agonists [59–61] or even transplants of serotonin and 
noradrenaline- producing cells into the spinal cord [62,63].  
The Bennett group studied a virtual “stepping response: to show serotonergic temporal synchrony, 
by observing the movement of the hindlimb of the hemisected spinal cord. Our empirical NMI data,  
in vivo, advances the Bennett paper and shows temporal synchrony between serotonin and movement 
exactly in motor neuroanatomy, the basal ganglia. Our data, shown above, are the first to show that 
temporal synchrony between serotonin and movement behavior occurs during natural behavior and is 
rendered dysfunctional during psychostimulant-induced, athetoid and dystonic behaviors. Therefore, in 
dystonic movement disorders as well as in spinal cord injury in patients and animals, serotonin and 
rhythmic movement are inseparable. Thus, NMI and the BRODERICK PROBE® provides advances 
for the diagnosis and treatment of a variety of dystonic movement disorders via the phenomenon of 
temporal synchrony between neuromodulators and movement directed within motor circuitry. 
10. Conclusions 
Described in this discourse is a dynamic concept of temporal synchrony in natural versus  
drug-induced movement behavior. Temporal synchrony patterns are shown between the 
neurotransmitter, serotonin, and movement behavior using NMI and the BRODERICK PROBE® 
microelectrodes and biosensors. Serotonin is imaged in dopamine motor pathways while open-field 
behavior is monitored with infrared photocell beams in the same animal subject. Temporal synchrony 
is described within the context of central pattern generators, repetitive discharge in cell firing and 
automaticity in co-relationship to open-field ambulatory and stereotypic movement behaviors.  
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The take-home messages from these studies are new findings [1] temporal synchrony between brain 
neurotransmitter and behavior is exhibited when injury is not present. Brain/behavior mechanisms are 
rhythmic and synchronous [2] dysfunctional behavior that is asynchronous and arrhythmic comprises 
temporal asynchrony. These temporal brain/behavior patterns using NMI enable the formation of  
a new and dynamic data profile. Temporal brain/behavior patterns are more relevant to the physician 
and scientist than are static parameters currently used in research for diagnosis and treatment of  
brain disease.  
Given the caveat that static levels of neurotransmitters are valuable, static parameters assume more 
value within the context of movement because dynamic data profiles provide more accurate clinical 
management. Disorders of basal ganglia, such as athetoid, dystonic disease may be studied with the 
BRODERICK PROBE®. The patient with spinal cord injury will benefit from diagnosis with this 
biosensor. It is concluded that the healthy brain and spinal cord in humans and animals may very much 
depend on patterns of brain/behavioral synchronicity.  
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